睿创微纳(688002) - 2025 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2025 reached ¥1,136,518,772.01, representing a 12.88% increase compared to ¥1,006,866,773.50 in the same period last year[4] - Net profit attributable to shareholders was ¥145,818,960.66, up 13.42% from ¥128,567,050.65 year-on-year[4] - Total operating revenue for Q1 2025 reached ¥1,136,518,772.01, an increase of 12.9% compared to ¥1,006,866,773.50 in Q1 2024[19] - Net profit for Q1 2025 was ¥113,414,552.11, representing a 11.5% increase from ¥101,847,772.69 in Q1 2024[21] - The basic earnings per share increased to ¥0.3205, reflecting an 11.52% growth from ¥0.2874 in the same quarter last year[4] - The diluted earnings per share rose to ¥0.3161, marking a 12.41% increase compared to ¥0.2812 in the prior year[4] - Basic earnings per share for Q1 2025 were ¥0.3205, compared to ¥0.2874 in Q1 2024, reflecting a growth of 11.5%[21] Cash Flow - The net cash flow from operating activities increased by 46.52%, amounting to ¥236,023,467.99, driven by higher cash receipts from sales[4][8] - Cash inflow from operating activities for Q1 2025 was $1,405,927,831.91, a 52.8% increase from $919,333,886.70 in Q1 2024[23] - Net cash flow from operating activities for Q1 2025 was $236,023,467.99, up 46.4% from $161,085,689.28 in Q1 2024[23] - Cash outflow from investing activities for Q1 2025 was $1,195,471,145.87, a slight decrease of 3.3% compared to $1,236,325,947.32 in Q1 2024[24] - Net cash flow from investing activities for Q1 2025 was -$502,327,254.25, worsening from -$265,120,511.04 in Q1 2024[24] - Cash inflow from financing activities for Q1 2025 was $128,399,922.13, down 41.2% from $218,011,053.92 in Q1 2024[25] - Net cash flow from financing activities for Q1 2025 was $20,847,638.78, a decrease of 46.8% compared to $39,181,467.55 in Q1 2024[25] - The ending cash and cash equivalents balance for Q1 2025 was $763,164,667.89, down from $1,264,436,142.70 in Q1 2024[25] Research and Development - R&D expenses totaled ¥233,302,026.22, which is 20.53% of revenue, up from 17.87% in the previous year, indicating a focus on innovation[5] - Research and development expenses for Q1 2025 were ¥233,302,026.22, up from ¥179,954,900.72 in Q1 2024, reflecting a growth of 29.6%[20] Assets and Liabilities - Total assets at the end of the reporting period were ¥9,084,179,309.91, a 3.16% increase from ¥8,806,196,667.92 at the end of the previous year[5] - Total liabilities rose to ¥3,381,257,515.85, compared to ¥3,275,717,593.36, indicating an increase of 3.2%[17] - The company's total current assets amounted to approximately ¥5.03 billion, an increase from ¥4.78 billion as of December 31, 2024, reflecting a growth of about 5.1%[15] - The company's total non-current assets were approximately ¥3.06 billion, with a slight increase from ¥3.05 billion, reflecting a growth of about 0.3%[15] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 16,732, indicating a stable shareholder base[10] - The shareholder structure indicates that the top 10 shareholders hold significant stakes, with the largest shareholder holding 69.5 million shares, which is crucial for understanding ownership dynamics[12] Other Notable Information - The company reported non-recurring gains of ¥13,272,469.11 after tax, primarily from government subsidies and other non-operating income[7] - The company has not reported any new product launches or technological advancements during this period[13] - There are no significant mergers or acquisitions reported in the recent financial disclosures[13] - The company has not provided specific future guidance or market expansion strategies in the latest conference call[13]